Cosmetics News and Research

RSS

FDA approves first drug with digital ingestion tracking system

The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken.

14 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

FDA grants clearance to new blood cell count test that allows faster availability of results

The U.S. Food and Drug Administration today cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians' offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results.

6 Nov 2017

FDA issues warning letters to companies illegally selling products that claim to cure cancer

As part of the U.S. Food and Drug Administration's ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.

2 Nov 2017

Scientists develop bioluminescent enzymatic test system for assessing toxicity of nanomaterials

Official website of the Russian Science Foundation reports that a group of scientists from Siberian Federal University and Krasnoyarsk Scientific Center of the SB RAS has developed a bioluminescent enzymatic test system for assessing the toxicity of carbon nanomaterials.

2 Nov 2017

FDA grants accelerated approval to new treatment for mantle cell lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.

1 Nov 2017

FUJIFILM SonoSite to exhibit innovative portfolio of ultrasound solutions at ACEP 2017

FUJIFILM SonoSite, Inc., specialists in developing cutting-edge ultrasound solutions and providing world-leading education to enable point-of-care visualization access, will present its innovative portfolio of ultrasound solutions and highlight product features and upgrades at the American College of Emergency Physicians Annual Scientific Assembly, October 29 - November 1 in Washington, DC.

28 Oct 2017

FDA clears new Senhance System that can help facilitate minimally invasive surgery

Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device that can help facilitate minimally invasive surgery.

16 Oct 2017

First 7T MRI system receives FDA clearance for clinical use in the United States

Today, the U.S. Food and Drug Administration cleared the first seven tesla (7T) magnetic resonance imaging (MRI) device, more than doubling the static magnetic field strength available for use in the United States.

16 Oct 2017

FDA approves new treatment option for patients with moderate to severe central sleep apnea

The U.S. Food and Drug Administration today approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea.

9 Oct 2017

FDA grants approval for new test to detect Zika virus in blood donations

The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors.

6 Oct 2017

New spray drying technique helps reduce concentration of active ingredients in therapeutic drugs

Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medications.

5 Oct 2017

FDA approves FreeStyle Libre Flash Glucose Monitoring System for adult patients with diabetes

The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip.

27 Sep 2017

FDA participates in major global operation to target illegal prescription drugs sold online

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, recently took action against more than 500 websites that illegally sell potentially dangerous, unapproved versions of prescription medicines, including opioids, antibiotics and injectable epinephrine products to American consumers.

25 Sep 2017

Lead in water leading to problems with fertility and childbirth in Flint, Michigan

Researchers from the University of Kansas, Department of Economics in a new working paper series in Theoretical and Applied Economics write that with the change in water sources in Flint, Michigan since April 2014, lead exposure to the population has risen.

22 Sep 2017

First duodenoscope with disposable distal cap approved by FDA

The U.S. Food and Drug Administration today cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for cleaning and reprocessing.

20 Sep 2017

Study finds unsafe lead levels in red cosmetic powder used during Hindu ceremonies

Sindoor -- a cosmetic powder sold in the United States and used during Hindu religious and cultural ceremonies -- has unsafe levels of lead, according to a Rutgers University study.

19 Sep 2017

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.

14 Sep 2017

FDA grants approval for new biosimilar to treat multiple types of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.